Association of gut microbiome diversity and composition with pathological complete response (pCR) after neoadjuvant chemotherapy in triple negative breast cancer

被引：0
|
作者：
Vernaci, G. [1 ]
Cumerlato, E. [1 ]
Griguolo, G. [1 ]
Massa, D. [1 ]
Menichetti, A. [1 ]
Miglietta, F. [1 ]
Tasca, G. [2 ]
Savarino, E. [1 ]
Conte, P. F. [1 ]
Guarneri, V. [1 ]
Dieci, M. V. [1 ]
机构：
[1] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[2] IOV Ist Oncol Veneto IRCCS, Med Oncol Unit 2, Padua, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.03.039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
99P
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [21] Disparities Influence Pathologic Complete Response Rates After Neoadjuvant Chemotherapy In Triple Negative Breast Cancer
    Calvo, C.
    Colton, A.
    Hester, C. A.
    Xu, X.
    Zhu, H.
    Partain, N. S.
    Wooldridge, R.
    Farr, D.
    Huth, J.
    Leitch, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S101 - S101
  • [22] Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
    Wu, Kunpeng
    Yang, Qiaozhu
    Liu, Yi
    Wu, Aibing
    Yang, Zhixiong
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [23] Response to Neoadjuvant Chemotherapy of Triple Negative Breast Cancer
    Tokudome, N.
    Ito, Y.
    Takahashi, S.
    Sugihara, T.
    Hosonaga, M.
    Iwasaki, R.
    Hattori, M.
    Fukuda, T.
    Mitsuhashi, K.
    Kobayashi, K.
    Taira, S.
    Saito, Y.
    Fukada, I
    Ueki, N.
    Tsutsumi, C.
    Miyagi, Y.
    Iwase, T.
    Osako, T.
    Horii, R.
    Akiyama, F.
    Hatake, K.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 571S - 572S
  • [24] Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy
    Kunpeng Wu
    Qiaozhu Yang
    Yi Liu
    Aibing Wu
    Zhixiong Yang
    [J]. World Journal of Surgical Oncology, 12
  • [25] Prediction of pathological complete response to neoadjuvant chemotherapy in early triple negative breast cancer patients by serial breast ultrasound examination
    Rapoport, Bernardo
    Smit, Teresa
    Heyman, Liezl
    Moosa, Farhana
    Benn, Carol Ann
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [26] Improving pathological complete response in luminal breast cancer after neoadjuvant chemotherapy
    Cudos, Ariadna Gasol
    Murillo, Serafin Morales
    Galindo, Alvaro Rodriguez
    Subirats, Ona Pallise
    Olive, Jordi Mele
    Morales, Carles Canosa
    Villellas, Felip Vilardell
    Guzman, Douglas Rene Sanchez
    Rodriguez, Joel Veas
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [27] Demographic determinants of pathological complete response after neoadjuvant chemotherapy in breast cancer
    Dharanikota, A.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1482 - S1482
  • [28] Characteristics of breast cancer patients with pathological complete response after neoadjuvant chemotherapy
    Kolacinska, Agnieszka
    Blasinska-Morawiec, Maria
    Dowgier-Witczak, Izabela
    Kordek, Radzislaw
    Morawiec, Zbigniew
    [J]. MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2010, 9 (05): : 300 - 304
  • [29] A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
    Fournier, Marcia, V
    Goodwin, Edward C.
    Chen, Joan
    Obenauer, John C.
    Tannenbaum, Susan H.
    Brufsky, Adam M.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
    Marcia V. Fournier
    Edward C. Goodwin
    Joan Chen
    John C. Obenauer
    Susan H. Tannenbaum
    Adam M. Brufsky
    [J]. Scientific Reports, 9
12345